Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2018 at "American journal of ophthalmology"
DOI: 10.1016/j.ajo.2018.07.038
Abstract: OBJECTIVE To demonstrate the efficacy of the anti-interleukin-6 receptor monoclonal antibody tocilizumab in patients with moderate-to-severe corticosteroid-resistant Graves orbitopathy (GO). DESIGN Double-masked randomized clinical trial. METHODS Setting and Participants: Thirty-two adults with moderate-to-severe corticosteroid-resistant GO… read more here.
Keywords: severe corticosteroid; corticosteroid; week; trial ... See more keywords